4.6 Review

Potential effector and immunoregulatory functions of mast cells in mucosal immunity

期刊

MUCOSAL IMMUNOLOGY
卷 8, 期 3, 页码 444-463

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/mi.2014.131

关键词

-

资金

  1. French Fondation pour la Recherche Medicale FRM''
  2. Stanford Pediatric Research Fund
  3. Arthritis National Research Foundation
  4. National Institutes of Health [K99AI110645, U19 AI104209, NS 080062]
  5. Lucile Packard Foundation for Children's Health
  6. Stanford NIH/NCRR CTSA [UL1 RR025744]
  7. Postdoctoral Fellowship for Research Abroad of the Japan Society for the Promotion of Science
  8. Tobacco-Related Disease Research Program at University of California

向作者/读者索取更多资源

Mast cells (MCs) are cells of hematopoietic origin that normally reside in mucosal tissues, often near epithelial cells, glands, smooth muscle cells, and nerves. Best known for their contributions to pathology during IgE-associated disorders such as food allergy, asthma, and anaphylaxis, MCs are also thought to mediate IgE-associated effector functions during certain parasite infections. However, various MC populations also can be activated to express functional programs-such as secreting preformed and/or newly synthesized biologically active products-in response to encounters with products derived from diverse pathogens, other host cells (including leukocytes and structural cells), damaged tissue, or the activation of the complement or coagulation systems, as well as by signals derived from the external environment (including animal toxins, plant products, and physical agents). In this review, we will discuss evidence suggesting that MCs can perform diverse effector and immunoregulatory roles that contribute to homeostasis or pathology in mucosal tissues.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors

Bianca Balbino, Pauline Herviou, Ophelie Godon, Julien Stackowicz, Odile Richard-Le Goff, Bruno Iannascoli, Delphine Sterlin, Sebastien Brule, Gael A. Millot, Faith M. Harris, Vera A. Voronina, Kari C. Nadeau, Lynn E. Macdonald, Andrew J. Murphy, Pierre Bruhns, Laurent L. Reber

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Immunology

Mouse Models and Tools for the in vivo Study of Neutrophils

Julien Stackowicz, Friederike Jonsson, Laurent L. Reber

FRONTIERS IN IMMUNOLOGY (2020)

Article Allergy

A highly sensitive bioluminescent method for measuring allergen-specific IgE in microliter samples

Sophie Goyard, Bianca Balbino, Rebecca S. Chinthrajah, Shu-Chen Lyu, Yves L. Janin, Pierre Bruhns, Pascal Poncet, Stephen J. Galli, Kari C. Nadeau, Laurent L. Reber, Thierry Rose

ALLERGY (2020)

Article Immunology

IgE Effector Mechanisms, in Concert with Mast Cells, Contribute to Acquired Host Defense against Staphylococcus aureus

Philipp Starkl, Martin L. Watzenboeck, Lauren M. Popov, Sophie Zahalka, Anastasiya Hladik, Karin Lakovits, Mariem Radhouani, Arvand Haschemi, Thomas Marichal, Laurent L. Reber, Nicolas Gaudenzio, Riccardo Sibilano, Lukas Stulik, Frederic Fontaine, Andre C. Mueller, Manuel R. Amieva, Stephen J. Galli, Sylvia Knapp

IMMUNITY (2020)

Correction Immunology

IgE Effector Mechanisms, in Concert with Mast Cells, Contribute to Acquired Host Defense against Staphylococcus aureus (vol 53, pg 793, 2020)

Philipp Starkl, Martin L. Watzenboeck, Lauren M. Popov, Sophie Zahalka, Anastasiya Hladik, Karin Lakovits, Mariem Radhouani, Arvand Haschemi, Thomas Marichal, Laurent L. Reber, Nicolas Gaudenzio, Riccardo Sibilano, Lukas Stulik, Frederic Fontaine, Andre C. Mueller, Manuel R. Amieva, Stephen J. Galli, Sylvia Knapp

IMMUNITY (2020)

Editorial Material Immunology

Editorial: Role of Neutrophils in Inflammatory Diseases

Thomas Marichal, Onur Boyman, Laurent L. Reber

FRONTIERS IN IMMUNOLOGY (2020)

Letter Allergy

Cardiovascular adverse effects of antieIL-5/IL-5Rα therapies: A real-world study

Jean-Baptiste Quinta, Francois Montastruc, Agnes Sommet, Anthony Touafchia, Michel Galinier, Laurent Reber, Vanessa Rousseau, Laurent Guilleminault

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Review Immunology

IgE in the pathophysiology and therapy of food allergy

Marine Michelet, Bianca Balbino, Laurent Guilleminault, Laurent L. Reber

Summary: Food allergy poses a significant public health issue without an approved therapy, with IgE antibodies playing a crucial role in diagnosis and treatment. Recent advances in regulating IgE production and understanding its function in food allergy offer hope for better management and treatment options. Clinical studies on anti-IgE therapeutic monoclonal antibodies provide insights into blocking IgE effector functions and improving outcomes for individuals with food allergies.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Article Allergy

IgE antibodies increase honeybee venom responsiveness and detoxification efficiency of mast cells

Philipp Starkl, Nicolas Gaudenzio, Thomas Marichal, Laurent L. Reber, Riccardo Sibilano, Martin L. Watzenboeck, Frederic Fontaine, Andre C. Mueller, Mindy Tsai, Sylvia Knapp, Stephen J. Galli

Summary: The study found that IgE sensitization enhances MC detoxification of honeybee venom by promoting proteolytic degradation and heparin-related interference with toxicity. This research emphasizes the importance of IgE, MCs, and specific MC products in defense against honeybee venom.

ALLERGY (2022)

Review Allergy

Focus on omalizumab in food allergy

M. Michelet, L. L. Reber, L. Guilleminault

Summary: Food allergy is a common disease with high morbidity and mortality, for which there is currently no approved therapeutic option. Oral immunotherapy (OIT) and monoclonal antibodies directed against IgE are potential strategies for treatment. Combining omalizumab with OIT appears to have promising results in increasing allergen tolerance and reducing side effects in food allergy patients.

REVUE FRANCAISE D ALLERGOLOGIE (2021)

Editorial Material Multidisciplinary Sciences

Comment on Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression

Jasper B. J. Kamphuis, William P. M. Worrall, Julien Stackowicz, Aurelie Mougel, Emilie Maure, Eva Conde, Pierre Bruhns, Laurent Guilleminault, Nicolas Gaudenzio, Jinmiao Chen, Rebecca Gentek, Laurent L. Reber

Summary: The researchers found that interleukin-33 can induce accumulation of tumor-associated macrophages expressing the Fc epsilon RI receptor, but raised concerns about the specificity of the anti-Fc epsilon RI antibody used in the study.

SCIENCE (2021)

Article Multidisciplinary Sciences

Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice

Eva Conde, Romain Bertrand, Bianca Balbino, Jonathan Bonnefoy, Julien Stackowicz, Noemie Caillot, Fabien Colaone, Samir Hamdi, Raissa Houmadi, Alexia Loste, Jasper B. J. Kamphuis, Francois Huetz, Laurent Guilleminault, Nicolas Gaudenzio, Aurelie Mougel, David Hardy, John N. Snouwaert, Beverly H. Koller, Vincent Serra, Pierre Bruhns, Geraldine Grouard-Vogel, Laurent L. Reber

Summary: The study developed vaccines targeting IL-4 and IL-13, demonstrating promising prophylactic and therapeutic effects in mouse models of asthma. Vaccines specific for human IL-4 and IL-13 also showed efficient neutralization of these cytokines in mice, suggesting a potential long-term therapeutic strategy for allergic asthma.

NATURE COMMUNICATIONS (2021)

Editorial Material Allergy

Development and preclinical evaluation of a vaccine targeting IL-4 and IL-13 for the treatment of allergic asthma

Eva Conde, Pierre Bruhns, Vincent Serra, Laurent L. Reber

ALLERGY (2021)

Article Immunology

Neutrophil-specific gain-of-function mutations in Nlrp3 promote development of cryopyrin-associated periodic syndrome

Julien Stackowicz, Nicolas Gaudenzio, Nadine Serhan, Eva Conde, Ophelie Godon, Thomas Marichal, Philipp Starkl, Bianca Balbino, Axel Roers, Pierre Bruhns, Friederike Jonsson, Philippe Moguelet, Sophie Georgin-Lavialle, Lori Broderick, Hal M. Hoffman, Stephen J. Galli, Laurent L. Reber

Summary: Gain-of-function mutations in NLRP3 gene cause CAPS, with neutrophils potentially being the main cellular drivers of CAPS pathology.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Immunology

Overexpression of the MSK1 Kinase in Patients With Chronic Lung Allograft Dysfunction and Its Confirmed Role in a Murine Model

Simona Nemska, Francois Daubeuf, Adeline Obrecht, Dominique Israel-Biet, Marc Stern, Romain Kessler, Antoine Roux, Reza Tavakoli, Pascal Villa, Adrien Tissot, Richard Danger, Laurent Reber, Eugenie Durand, Aurore Foureau, Sophie Brouard, Antoine Magnan, Nelly Frossard

Summary: The study demonstrates that inhibition of the proinflammatory mitogen- and stress-activated kinase 1 (MSK1) kinase can effectively alleviate damage caused by lung transplantation, suggesting its potential as a therapeutic target for chronic lung allograft dysfunction (CLAD).

TRANSPLANTATION (2021)

暂无数据